Norway - Healthcare, Regulatory and Reimbursement Landscape

Norway - Healthcare, Regulatory and Reimbursement Landscape

  • May 2021 •
  • 150 pages •
  • Report ID: 6073096 •
  • Format: PDF
Norway - Healthcare, Regulatory and Reimbursement Landscape

Summary
The analyst has released its latest report, "Norway - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in Norway.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Norway pharmaceutical market was worth $3.29 in 2013, which decreased to $3.26B in 2019 at a negative CAGR of 0.13%. The market value is expected to decrease further to $3.23B by 2025. Norway is a well-developed healthcare market in Northern Europe with the patient-centered approach towards care and treatment, data-driven innovation, and universal health coverage. In January 2016, the Norwegian Directorate of eHealth (NDE) was established to implement several national eHealth policies and encourage the adoption of digital health solutions.

Norway’s robust healthcare system, increasing elderly population, increased prevalence of chronic diseases, and growing pharmaceutical consumption are attributed to the growth of the pharmaceutical market.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Norway, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, Sanofi, GSK, and Navamedic
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche, Alcon, and Photocure
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Norway healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Norway’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Norway’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.